On September 6, China Life Group announced that the Ministry of Finance will inject 35 billion yuan into China Life Insurance (Group) Company. This capital infusion is designed to further bolster the company's operational stability and its capacity to withstand risks, providing renewed momentum for the group to concentrate on its core business, enhance corporate governance, and pursue differentiated development.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.